Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144] (European Journal of Pharmacology (1998) 342(1) (67–76), (S0014299997014179), (10.1016/S0014-2999(97)01417-9))
Ismaeil Haririan
Ismaeil Haririan

Professor of Pharmaceutics

Department Pharmaceutical Biomaterials

School of Pharmacy

Medical Biomaterials Research Center

Tehran University of Medical Sciences

All Documents